Health
PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs – Technology Networks
Scientists have shown that PD-L1 is a potential anti-cancer therapy target for the treatment of metastasized oral malignant melanoma in dogs.
Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.
There are a number of cancers that affect dogs, but there are far fewer diagnosis and treatment options for these canine cancers. However, as dogs and humans are both mammals, it is likely that strategies and treatments for cancers in humans can be used for canine cancer, with minor modifications.
A team of scientists, including Associate Professor Satoru…
-
General17 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General12 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
General13 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General21 hours agoLondon plane trees to be removed in Hamilton following infrastructure concerns